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In vivo monitoring of a cAMP-stimulated 
DNA-binding activity 
Falk Weih, A. Francis Stewart, Michael Boshart, Doris Nitsch, and Giinther Schlitz 
Institute of Cell and Tumor Biology, German Cancer Research Center, D-6900 Heidelberg, FRG 
The transcriptional ctivity of the tyrosine aminotransferase (TAT) gene is influenced by two major signal 
transduction pathways, by glucocorticoids and by glucagon acting via cAMP. We analyzed the effect of cAMP 
on protein-DNA interactions in vivo and on the transcription rate of the TAT gene. We demonstrate hat a 
cAMP-responsive element (CRE) is located in a tissue-specific DNase l-hypersensitive r gion, 3.6 kb upstream 
of the start site of transcription. By using the genomic footprinting technique, we show that this sequence is
occupied by protein in uninduced cells and that the in vivo footprint is transiently increased upon cAMP 
induction. Protein binding at the TAT-CRE correlates with the rate of transcription of the TAT gene. 
Cycloheximide treatment reveals that the genomic footprint is subject o rapid turnover) however, subsequent 
cAMP induction in the continued presence of cycloheximide r stores the footprint partially. We conclude that 
as a part of the signal transduction pathway, a cAMP-dependent, post-translational modification increases the 
DNA-binding activity of a protein to the TAT-CRE and thereby stimulates the transcription rate of the TAT 
gene. 
[Key Words: In vivo footprinting; signal transduction; transcriptional regulation; cAMP; CRE-binding protein] 
Received September 14, 1989; revised version accepted April 23, 1990. 
Cells react o their environment by transducing extemal 
signals into intracellular responses. Two major distinct 
mechanisms of signal transduction have been eluci- 
dated. First, binding of the signaling molecule to intra- 
cellular eceptors directly, as exemplified by steroid hor- 
mones, influences gene activity by inducing DNA 
binding of the receptor. As a consequence of binding, 
chromatin structure is altered and the transcription rate 
of the corresponding gene is either increased or repressed 
(for reviews, see Yamamoto 1985; Evans 1988; Green 
and Chambon 1988; Beato 1989). By use of the genomic 
footprinting technique, it has been demonstrated that in 
vivo binding of steroid receptors to their target sites is 
dependent on the presence of the hormone (Becker et al. 
1986; Philipsen et al. 1988; Wijnholds et al. 1988}. 
Second, many polypeptide hormones and growth 
factors bind to specific cell-surface receptors and lead to 
altered intracellular levels of second messengers such as 
inositol-3-phosphate (IP-3), diacylglycerol (DAG), Ca ~+, 
and cAMP. These second messengers activate specific 
protein kinases which, in some cases, influence gene ac- 
tivity by as-yet-undetermined mechanisms {for reviews, 
see Hokin 1985; Edelman et al. 1987; Gilman 1987}. For 
instance, the transcriptional stimulation of the proto- 
oncogene c-los by epidermal growth factor (EGF) re- 
quires DNA sequences located between - 317 and - 290 
of the c-los 5'-flanking region, including the serum re- 
sponse lement (SRE; Treisman 1985). In contrast to the 
inducible binding of steroid hormone receptors, genomic 
footprinting has shown that the SRE is bound by pro- 
teins to the same extent before, during, and after induc- 
tion of the c-los gene (Herrera et al. 1989}. 
During the last several years, numerous genes re- 
sponding to elevated levels of cAMP have been analyzed. 
A cis-acting DNA sequence referred to as a cAMP-re- 
sponsive lement (CRE) has been characterized in many 
of these genes {Comb et al. 1986; Montminy et al. 1986; 
Delegeane t al. 1987; Silver et al. 1987; Tsukada et al. 
1987; Bokar et al. 1988; Quinn et al. 1988; Dean et al. 
1989; Fisch et al. 1989}. cAMP acts by binding to the 
regulatory subunit of the cAMP-dependent protein ki- 
nase (PK-A), thereby causing the regulatory and catalytic 
subunits of the holoenzyme to dissociate (for review, see 
Edelman et al. 1987). This results in transcriptional cti- 
vation of certain genes, possibly via direct phosphoryla- 
tion of transcriptional regulatory proteins (Yamamoto et 
al. 1988; Bagchi et al. 1989; Gonzalez and Montminy 
1989). 
We are analyzing the transcriptional regulation of the 
tyrosine aminotransferase (TAT)gene, which is ex- 
pressed exclusively in parenchymal cells of the liver (for 
review, see Hargrove and Granner 1985). This gene is 
transcriptionally responsive to members of both classes 
of signal transduction. The sequence through which the 
glucocorticoid receptor, acts [glucocorticoid responsive 
element (GREI] to stimulate the TAT gene was initially 
identified by an inducible DNase i hypersensitive (HS) 
site (Becker et al. 1984) and subsequently characterized 
in detail by gene transfer experiments (Jantzen et al. 
19871. Upon administration of glucocorticoids, a local 
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chromatin change results, as revealed by HS site map- 
ping and genomic footprinting (Becker et al. 1986; 
Jantzen et al. 1987). A functional GRE is 15 bp long and 
acts as an inducible transcriptional enhancer when mul- 
timerized (Str/ihle et al. 1988). Apart from glucocorticoid 
induction, the activity of the TAT gene is also regulated 
on the transcriptional level by glucagon via its intracel- 
lular mediator, cAMP (Hashimoto et al. 1984; Schmid et 
al. 1987). 
Here, we report that after cAMP stimulation, an in 
vivo footprint on a sequence with close homology to 
known CREs alters in parallel to the transcription rate of 
the TAT gene. These alterations are also apparent as 
changes in the DNA-binding activity of a factor in vitro. 
We show that cAMP-mediated signal transduction to 
the TAT gene involves post-translational modifications, 
which affect a factor's DNA-binding activity. 
Results 
A DNase I HS region centered around -3 .6  kb is 
correlated with active TAT gene transcription 
The initial indication that a regulatory element of the 
TAT gene is located farther upstream than the GRE at 
-2 .5  kb was obtained by DNase I HS site mapping. In 
TAT-expressing FTO-2B hepatoma cells (Killary and 
Foumier 1984), a strong HS site around -3.6 kb can be 
detected (Fig. 1A; HS site -3.6). This HS is dependent 
neither on dexamethasone or on cAMP induction. In 
contrast, the HS site at -2.5 kb is not present in the 
absence of glucocorticoids, as described earlier (Becker et 
al. 1984; Jantzen et al. 1987). The TAT nonexpressing 
fibrosarcoma cell line XC (Svoboda 1960)does not show 
these HS sites, whether they have been induced or not. 
Precise mapping of HS site -3.6 shows that intense 
DNase I cleavages are found in the region between 
-3500 and -3800 (Fig. 1 and data not shown). A de- 
tailed analysis of the chromatin structure of the TAT 
gene will be published elsewhere (D. Nitsch et al., in 
prep.). 
Genomic footprinting reveals specific protein-DNA 
interactions at a CRE-related sequence 
To analyze the DNase I HS region at -3.6 kb in greater 
detail, we applied the genomic footprinting technique 
(Church and Gilbert 1984) to FTO-2B, and as a control, 
to XC cells. Treatment of intact cells with dimethyl sul- 
fate (DMS)results in methylation of guanosines at the 
N7 position in the major groove, rendering them suscep- 
tible to cleavage with piperidine (Maxam and Gilbert 
1980). Specific guanosine residues closely associated 
with a protein will be protected from methylation by 
DMS. Enhanced reactivity of certain guanosines may re- 
sult when protein-DNA interactions generate a local 
hydrophobic environment close to a target guanine (Gil- 
bert et al. 1976). In addition, protein-induced local alter- 
Figure 1. The DNase I HS site 3.6 kb up- 
stream is present only in TAT-expressing 
cells. (A} Nuclei were isolated from FTO- 
2B cells and uninduced XC cells {XC). 
FTOo2B cells were either incubated in serum- 
free medium (FTO), induced for 1 hr with 1 
~M dexamethasone {FTO/DEX), or incubated 
for 1 hr in the presence of 0.5 mM cAMP 
(FTO/cAMP). Preparations of isolated nuclei 
were digested with increasing amounts of 
DNase I for 10 rain on ice. Numbers above 
each lane indicate the DNase I concentration 
used {in U/ml) reaction volume. DNA was 
purified and, after digestion with BamHI, sep- 
arated on a 1% agarose gel (20 ~g/lane), 
blotted, and hybridized. The probe was a T3- 
RNA polymerase transcript from subclone 
pEB670 (- 1974 to - 1301) of the TAT gene. 
(M) End-labeled k marker DNA whose size (in 
kb} is indicated at left. The HS sites at -3.6 
and -2.5 are indicated by arrows. (B)The 5'- 
flanking region of the TAT gene, including 
DNase I HS sites up to -6  kb is depicted. 
The glucocorticoid-inducible HS site at -2.5 
is labeled with GRE. The constitutive HS site 
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ations in DNA conformation may alter the reactivity of 
guanine residues against DMS (Johnsrud 1978). 
Whereas the reaction pattern obtained from XC cells 
is essentially indistinguishable from partially methyl- 
ated protein-free DNA (not shown), FTO-2B cells dem- 
onstrate a pattern of protections and enhancements, in-
dicating the binding of protein. As Figure 2 shows, the 
5'-boundary of this in vivo footprint is marked by a hy- 
perreactive guanosine at -3651 on the lower strand 
(lower, FTO-2B) and by a very strong enhancement at G 
-3649 on the upper strand (upper, FTO-2B). All of the 
guanosine residues on either strand down to G -3643, 
which again shows enhanced reactivity, are at least par- 
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Figure 2. In vivo footprinting experiments reveal protein- 
DNA interactions within HS site -3.6. XC and FTO-2B cells 
were incubated with DMS for 5 min at room temperature. After 
purification, DNA was digested with StyI and the backbone 
was cleaved at positions of methylated guanosines with piperi- 
dine. Thirty micrograms ofgenomic DNA per lane was electro- 
phoresed on a 6% denaturing polyacrylamide gel, electroblotted 
onto GeneScreen, baked at 80°C, and covalently cross-linked by 
UV irradiation. Membranes were then hybridized with a single- 
stranded DNA probe of high specific activity. Guanosine res- 
idues that show an altered reactivity in FTO-2B cells, as com- 
pared to XC cells: enhancements (m); protections (D). (Bottom) 
The location of the probe and the extent of the DNase I HS 
region at -3.6. Numbers indicate the position of base pairs rel- 
ative to the start site of transcription. 
cAMP-stimulated binding of a prote in  to a CRE 
tially protected from DMS attack. The differences in 
DMS reactivity of FTO-2B cells compared to XC cells 
are summarized in the middle of Figure 2. The sequence 
indicated by the genomic footprint is closely related to 
CREs, the binding site of the activating transcription 
factor (ATF) in several adenoviral genes, and the recogni- 
tion site of the Fos-Jun complex AP-1 (for review, see 
Jones et al. 1988). 
The TAT-CRE confers cAMP responsiveness to a 
heterologous promoter 
To test directly whether this sequence contacted by pro- 
tein in expressing cells fulfills the criteria of a CRE, we 
concatemerized a DNA fragment (-3659 to -3634), in- 
cluding the sequence covered by the in vivo footprint, 
and inserted it upstream of the herpes simplex virus- 
thymidine kinase (HSV-TK)promoter. As a control, we 
used a DNA fragment that differs from the original se- 
quence only by a triple-point mutation. We chose to 
mutate the three guanosine residues that are protected 
in the genomic footprint (see Fig. 2). The sequence of 
wild-type and mutated DNA fragments is presented in 
Figure 3B. The bacterial chloramphenicol acetyltrans- 
ferase (CAT) gene was used as reporter, and expression 
was monitored by analysis of CAT activity. Induction of 
transfected FTO-2B cells was carried out with forskolin, 
a drug that activates adenylate cyclase and thereby 
raises intracellular cAMP levels (Seamon et al. 1981). As 
shown in Figure 3A, the concatemerized TAT sequence 
is capable of conferring cAMP responsiveness to a heter- 
ologous promoter. CAT activity is stimulated 24-fold 
after only 4 hr of forskolin induction, indicating adirect 
response of the reporter plasmid to elevated intracellular 
cAMP levels. The basal evel expression of the mutated 
version is close to background and does not show signifi- 
cant stimulation after forskolin induction (less than 
threefold). Therefore, this sequence lement henceforth 
is referred to as TAT-CRE. Interestingly, the TAT- 
CRE also increases basal evel expression of the TK pro- 
moter by at least 15-fold. Inverting the orientation of the 
concatemerized fragments gives similar results (not 
shown). The effect on basal evel transcription mediated 
by the TAT-CRE correlates well with the observation 
that this sequence is occupied in vivo by protein already 
in the uninduced state (see Fig. 2). 
Mutations at the TAT-CRE affect both basal and 
cAMP-stimulated activities of the TAT promoter 
To demonstrate he functionality of the TAT-CRE at 
its natural position, we stably integrated TAT-CAT 
constructs into FTO-2B cells and examined the effects of 
GRE mutations on TAT-CAT RNA synthesis by ribo- 
nuclease protection experiments. As shown in Figure 
4A, a construct including the TAT-CRE (-3675)re- 
sponds to forskolin treatment, whereas a 5'-deletion to 
remove the TAT-CRE ( -3628)or the introduction of 
the same three point mutations at the TAT-GRE, as de- 
picted in Figure 3B, into the -3675-bp TAT-CAT con- 
struct (-3675/M3), results in a loss of cAMP responsive- 
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Figure 3. The TAT-CRE confers cAMP re- A. 
sponsiveness. (A)Oligonucleotides (six direct 
repeats; sequence in B) harboring either the 
wild-type (wt)or the mutated (rout)TAT- 
CRE were cloned in front of the HSV-TK 
promoter driving the bacterial CAT gene. 
FTO-2B cells were transfected by electropora- 
tion, split onto separate dishes, and either 
mock-induced with 0.1% ethanol or induced 
with 10 ~LM forskolin. Extracts were prepared 
4 hr after DNA transfer, and CAT assays 
were performed. CAT activities were cor- 
rected for a cotransfected luciferase standard 
driven by the Rous sarcoma virus long ter- 
minal repeat (RSV-LTR), and basal (unin- 
duced) activity of the mutated construct was 
arbitrarily defined as 1. (B) Sequence of oli- B. 
gonucleotides used for construction of re- 
porter plasmids and gel retardation experi- 
ments. Numbers refer to the position of bases 
relative to the start site of transcription. 
Three guanosine residues, which are pro- 
tected from DMS attack in vivo, were 
changed in the mutated version of the 
TAT-CRE (indicated by lowercase l tters and asterisks). 
-105 +1 
TK CAT 
- 105 +~=4~ 
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ness. Interestingly these mutations also reduce basal 
level expression >20-fold (quantitated by scintillation 
counting). In the lower part of Figure 4A, the signal from 
the endogenous TAT gene (E)is shown as a control. Ex- 
amination of 5' sequences up to -3923 bp did not alter 
cAMP responsiveness compared to the -3675 bp TAT-  
CAT construct (data not shown). From the ribonuclease 
protection experiments, we conclude that the TAT-  
CRE is essential for high basal level activity of the TAT 
promoter and, taken together with the results of Figure 
3, at least partly responsible for mediating the cAMP 
stimulation of TAT gene transcriptional activity. Be- 
cause we do not observe the same foldness of induction 
of the introduced gene as the endogenous one, it may be 
that a component missing from our experiments con- 
tributes to the cAMP response of the TAT gene. 
The in vivo footprint at the TAT-CRE and the 
transcription rate of the TAT gene transiently respond 
to cAMP 
Because the genomic footprint covers a DNA sequence 
involved in cAMP responsiveness, we analyzed the ef- 
fect of forskolin on the protein-DNA interactions in 
vivo. FTO-2B cells were stimulated with 10 ~M fors- 
kolin. After the times shown, the cells were reacted 
with DMS and, subsequently, genomic DNA was puri- 
fied and processed for genomic sequencing. Striking ef- 
fects were found in FTO-2B cells after 30 and 50 min of 
cAMP induction (Fig. 5A). Protein is already bound at 
the TAT-CRE in the uninduced state (lane 2), and foot- 
print strength is increased approximately threefold upon 
forskolin administration (lanes 3 and 4). Interestingly, 
the intensification of the footprint is transient and de- 
creases after prolonged incubation of FTO-2B cells with 
forskolin. The demonstration of a genomic footprint at 
the TAT-CRE in uninduced FTO-2B cells (see Figs. 2 
and 5) is consistent with a DNase I HS site at -3 .6 kb in 
the uninduced state. 
To quantify the recorded effects, densitometric scan- 
nings from the autoradiograph were made. The degree of 
protein-DNA interaction was correlated to hyperreacti- 
vity of G-  3649 on the upper strand and compared under 
noninducing and inducing conditions. Basal level of 
footprinting activity at the TAT-CRE in uninduced 
FTO-2B cells was arbitrarily defined as one relative foot- 
print unit. The result is summarized in the lower part of 
Figure 5A. 
To correlate transcriptional ctivation of the promoter 
more precisely with increased footprint activity at the 
TAT-CRE upon cAMP induction, nuclear un-on anal- 
ysis with FTO-2B cells was performed. Figure 5B shows 
the result of this experiment. The transcription rate of 
the TAT gene in FTO-2B cells is increased fivefold, it 
peaks -~60 rain after forskolin administration, and de- 
clines again after 90 min. These experiments demon- 
strate a correlation between enhanced protein-DNA in- 
teractions at the TAT-CRE and the increased rate of 
TAT gene transcription i  cAMP-induced FTO-2B cells. 
This result is consistent with the observation of Hashi- 
moto et al. (1984), who found that transcriptional stimu- 
lation of the TAT gene in rat liver by cAMP is also tran- 
sient. 
The genornic footprint at the TAT-CRE is abolished by 
cycloheximide but can be restored partially by cAMP 
To address the question whether the intensification of 
the footprint at the TAT-CRE is due to a cAMP-me- 
diated post-translational event, protein synthesis was 
blocked with cycloheximide (CHX). The concentration 
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Figure 4. The TAT-CRE is functional in its natural context. 
(A) Different TAT 5'-flanking sequences were cloned in front of 
the bacterial CAT gene and stably integrated into FTO-2B cells. 
RNA was prepared from untransfected and uninduced control 
cells (C) and stably transfected pools that were treated with 
0.1% ethanol ( - ) or induced with 10 ~M forskolin for 1 hr (1), 2 
hr (2), and 4 hr (4). -3675 and -3628 denote the 5'-deletion 
end point of TAT-CAT constructs (in base pairs), -3675/M3 
denotes aconstruct where the TAT-CRE has been mutated by 
the same 3-bp exchanges as shown in Figure 3B. Total RNA (40 
~g) was hybridized to 10 fmoles of a uniformly labeled anti- 
sense SP6 transcript and digested with RNase A and T1. Pro- 
tected fragments were separated on a 7.5% sequencing gel. The 
gel shown for the TAT-CRE mutants (-3628 and -3675/M3) 
was exposed for a longer time to compensate for the reduced 
signals. The endogenous TAT gene (E)serves a a control and 
displays microheterogeneity at its start site. {CS) Correctly ini- 
tiated transcripts; (RT)readthrough transcripts; (P) undigested 
probe; (M) end-labeled marker; fragment sizes (in bp) are indi- 
cated at left. (B) Expected fragments protected from ribonu- 
clease digestion are shown with their calculated size. 
of CHX used (50 ~g/ml)was more than sufficient to 
block protein synthesis completely, as assayed by incor- 
poration of [3SS]methionine (not shown). As a first con- 
trol, uninduced FTO-2B cells were treated for increasing 
length of time with CHX. Surprisingly, we found that 
the in vivo footprint at the CRE becomes weaker and 
completely disappears after 3 -4  hr (Fig. 6A, lanes 5 and 
6). This finding indicates that ongoing protein synthesis 
is required to maintain basal-level binding activity to 
the TAT-CRE. To quantify the half-life of this footprint 
activity, the autoradiograph was scanned and evaluated 
as outlined above. The result is shown in the lower part 
of Figure 6A. After 60-75 rain of incubation with CHX, 
50% of the DNA binding activity to the TAT-CRE is 
abolished. 
Subsequently, we treated FTO-2B cells with CHX for 
3 hr to clear the TAT-CRE of binding and then induced 
with 10 ~M forskolin. As shown in Figure 6B, the in vivo 
footprint can be restored, at least partially. This induc- 
tion is also transient, and the kinetics are very similar to 
those observed above with cells that have not been 
treated with CHX (see Fig. 5). The reduced intensity of 
the footprint stimulated by cAMP in the presence of 
CHX may be due to a decreased amount of the relevant 
binding activity in the cell. If forskolin is added to the 
cells in parallel with CHX, the effect is similar to the 
result shown in Figure 5A, although the footprint ac- 
tivity is slightly reduced (not shown). 
To correlate the result shown in Figure 6A with TAT 
gene expression, we performed Northern analysis of un- 
induced and forskolin-induced hepatoma cells in the 
presence or absence of CHX. Figure 6C shows that CHX 
treatment significantly reduces TAT mRNA in unin- 
duced and forskolin-induced cells. As a control we 
probed for GAPDH mRNA, which is not affected by ei- 
ther CHX or forskolin treatment. 
These results indicate that (1) the occupancy of the 
TAT-CRE in the uninduced state is subject o turnover, 
and (2)cAMP, by a post-translational mechanism, in- 
creases footprinting activity on the TAT-CRE. 
In vitro binding analyses of protein-DNA interactions 
at the TA T-CRE confirm in vivo observations 
To analyze the protein interaction with the TAT-CRE 
in greater detail, we attempted to complement the above 
results by in vitro binding assays. The sequences of the 
TAT gene-specific oligonucleotides u ed in gel retarda- 
tion assays (Fried and Crothers 1981; Garner and Revzin 
1981) are shown in Figure 3B. Figure 7A shows that two 
specific complexes--A and B--form with the TAT-  
CRE but not with the mutated sequence. In a competi- 
tion experiment only the wild-type fragment competes 
for complexes A and B; no competition is observed with 
the mutated binding site, even at a 400-fold molar excess 
(Fig. 7B). 
To search for possible differences in the way A and B 
recognize DNA, methylation interference analysis (Sie- 
benlist and Gilbert 1980)with both complexes was per- 
formed. As shown in Figure 7G, methylation of G 
-3649, G -3647, A -3644, and G -3643 on the upper 
strand and G -3648, G -3645, and G -3642 on the 
lower strand strongly interferes with formation of com- 
plex B. The methylation interference pattern correlates 
with the methylation protection pattern of the genomic 
footprint (see lower part of Fig. 7G). The methylation 
interference pattern of complex A is identical, although 
generally less pronounced (not shown). It appears that 
the proteins involved in the formation of both corn- 
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F igure  5. The in vivo footprint at the TAT- 
CRE and the TAT gene transcription rate 
transiently respond to cAMP. {A) FTO-2B 
cells were induced for the indicated periods 
with 10 wra forskolin. After in vivo methyl- 
ation, purified DNA was further processed as 
detailed in Fig. 2. (F) Forskolin induction. 
Symbols and numbering are as detailed in Fig. 
2. The autoradiograph shown at top was 
quantified by densitometric s annmgs on a 
Hirschmann Elscript 400 scanner. Footprint 
activity in umnduced FTO-2B cells was cor- 
related to hyperreactivity of G -3649 and ar- 
bitrarily defined as 1 relative footprint unit. 
(B} Nuclear un-on analysis of nuclei prepared 
from FTO-2B cells induced for the indicated 
periods with 10 gra forskolin. Quantification 
was done by Cerenkov counting. The values 
(in cpm) for the relative transcription rate of 
the TAT gene are shown in the diagram. 
(GAPDH} glyceraldehyde-3-phosphate-dehy- 
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plexes contact he same bases and bind with comparable 
affinities to the TAT-CRE. 
To establish a correlation of the in vivo findings with 
the situation in vitro, we looked for changes of protein- 
DNA interactions in gel retardation experiments after 
treatment of hepatoma cells with either cAMP or CHX. 
Therefore, we prepared nuclear extracts from FTO-2B 
cells that were induced for 30 min with 10 ~M forskolin. 
Because we realized that the ratio between complexes A
and B varied in different extract preparations, the un- 
treated control extracts were prepared in parallel; Figure 
7C shows the result of this experiment. In extracts pre- 
pared from forskolin-induced cells, the formation of 
complex B is increased 3.5-fold (quantified by densito- 
metric scannings), whereas formation of complex A is 
not influenced at all. The increase in DNA-binding ac- 
tivity in this assay correlates well with the results ob- 
tained from the genomic footprinting analysis. 
Similarly, nuclear extracts from cells treated with 
CHX {50 ~g/ml}, or untreated, were prepared. Again, 
only complex B was affected by CHX treatment being 
almost completely abolished, whereas complex A was 
not influenced {Fig. 7C}. From these results, we con- 
cluded that the effects observable by in vivo footprinting 
are mediated by alterations in the DNA-binding activity 
of a protein that forms complex B in a gel retardation 
assay. 
Because the TAT-CRE is closely related to the so- 
matostatin CRE (Montminy et al. 1986}, we compared 
both sequences directly in gel retardation assays. As 
shown in Figure 7D, three complexes (B, C, and D)form 
with the labeled somatostatin CRE, only one of which 
comigrates with complex B of the TAT-CRE. When the 
somatostatin CRE is used as a competitor to the labeled 
TAT-CRE, only complex B is competed, whereas com- 
plex A remains unchanged (see Fig. 7E}. This experiment 
suggests that the protein forming complex B with the 
TAT-CRE also binds to the somatostatin CRE. How- 
ever, the reverse experiment does not deliver the com- 
plementary result. When the somatostatin CRE is used 
as labeled fragment, the TAT-CRE does not compete 
significantly for any of the three complexes we observe 
{data not shown}. Furthermore, when the somatostatin 
CRE is used with the same nuclear extracts as shown in 
Figure 7C in a gel retardation assay, neither a forskolin- 
dependent increase nor a CHX-caused decrease in com- 
plex formation is observed with any of the three com- 
plexes, B, C, or D {Fig. 7F}. Taken together, these results 
indicate that the TAT-CRE is recognized ifferently 
than the somatostatin CRE. 
Discuss ion  
We analyzed protein-DNA interactions of the TAT 
gene in intact rat hepatoma cells and identified in vivo a 
footprint over a sequence lement hat bears homology 
to known CREs. That this element mediates cAMP re- 
sponsiveness and contributes to the basal level of TAT 
gene transcription was demonstrated by gene transfer 
experiments. We show elsewhere {Boshart et al. 1990} 
that this element acts synergistically with a hepatocyte- 
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Figure 6. The in vivo footprint at the TAT- 
CRE is sensitive to CHX but can be restored 
partially by cAMP. {A) FTO-2B cells were in- 
cubated for the indicated periods with 50 
~g/ml CHX, and DNA was then methylated 
in vivo and processed further as outlined in 
Fig. 2. (B) FTO-2B cells were incubated for 3 
hr with 50 ~g/ml CHX and subsequently in- 
duced for the indicated periods with 10 ~M 
forskolin in the continuing presence of CHX. 
Quantitation of footprint activity, symbols, 
and abbreviations are as detailed in Figs. 2 
and 5. [C) CHX affects TAT mRNA levels. 
Cells were either not induced or induced 
with 10 ~M forskolin in the presence or ab- 
sence of CHX {50 ~g/ml) for 6 hr. The signal 
for GAPDH mRNA on the same Northem 
blot is shown as a control. 
specific constitutive lement located in close proximity 
to the TAT-CRE.  Because the maximal transcriptional 
response of the TAT gene to cAMP is transient, we 
looked for and found transient responsiveness of the ge- 
nomic footprint. Intensity of the footprint and the tran- 
scriptional response showed similar kinetics following 
cAMP induction, strongly suggesting that the increased 
rate of transcription is a consequence of increased for- 
mation of this p ro te in -DNA complex. The inducible 
prote in -DNA interaction can also be observed by in 
vitro DNA binding assays with the TAT-CRE.  
The genomic footprint at the TAT-CRE is influenced 
in two ways. First, it is transiently intensified by cAMP, 
even in the presence of CHX, indicating that a post- 
translational event is involved in the increased footprint 
strength. Second, the footprint is abolished by CHX 
treatment, suggesting that ongoing protein synthesis is 
required for its maintenance and that the DNA-binding 
activity of this protein is subject o tumover. This could 
involve synthesis and degradation of the protein itself 
or, more likely, mechanisms that cycle its DNA-binding 
activity. From these observations, we conclude that the 
DNA-binding activity of this protein can be influenced 
by interference with protein synthesis and by a post- 
translational modification. 
A model for this post-translational modification in- 
volves protein phosphorylation by the catalytic subunit 
of PK-A, which may result in a conformational change of 
the TAT-CRE-binding protein. Although we have not 
ascertained whether the TAT-CRE-binding factor is a 
phosphoprotein, it has been demonstrated that the tran- 
scriptional stimulation of the TAT gene by cAMP is me- 
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Figure 7. In vitro analyses of protein-DNA interactions at the TAT-CRE. Nuclear extract protein (25 ~g) was incubated on ice with 
sonicated herring sperm DNA (100 ~g/ml) and ---5 fmoles of labeled fragment carrying the TAT-CRE, as detailed in Materials and 
methods. After the binding reaction, samples were loaded onto a 4% native polyacrylamide gel and electrophoresed at 9 V/cm. The 
gels were removed from the glass plates, dried, and exposed to X-ray films. (A) Two strong complexes (A and B) can be detected with 
the wild-type (wt) TAT-CRE sequence, but neither forms with the mutated (rout) version. (B) Formation of complexes A and B can be 
specifically competed. The indicated amounts of unlabeled competitor f agments (wt or mut) were added to the reaction mixture. 
Numbers indicate the molar excess of unlabeled competitor DNA over labeled fragment. (C) Complex B responds to forskolin induc- 
tion and is sensitive to CHX. The TAT-CRE fragment (wt) was end-labeled and i cubated with nuclear extracts prepared either from 
untreated, forskolin-induced, orCHX-treated cells. (D) Three complexes (B-D) can be detected with the somatostatin CRE. Only one 
comigrates with complex B of the TAT-CRE. (TAT) Labeled TAT-CRE; (SOM) labeled somatostatin CRE. (E) The somatostatin CRE 
specifically competes for complex B but not for complex A of the TAT-CRE. Numbers are as in B. (F) None of the somatostatin-spe- 
cific complexes responds to forskolin or is sensitive to CHX. The somatostatin CRE fragment was end-labeled and incubated with the 
same extracts hown in C. (G) Methylation interference assay for complex B. A preparative gel retardation experiment with partially 
methylated TAT-CRE fragment (wt) and FTO-2B nuclear extracts was carried out. DNA from complexes (bound, B) and from the 
unretarded fraction (free, F} was isolated as detailed in Materials nd methods, cleaved with piperidine, and separated on a 10% 
denaturing polyacrylamide g l. The nucleotide sequence of the upper and lower strand are indicated at left and right, respectively. (A) 
Purine residues whose methylation i terferes with complex formation. The methylation i terference pattern of complex B is summa- 
rized at bottom. The in vivo DMS footprint at the TAT-CRE is indicated in the center, as detailed in Fig. 2. 
diated by the catalytic subunit of PK-A (Schmid et al. 
1987; Bfichler et al. 1988). Protein phosphorylation, 
which leads to increased DNA-binding activity of the 
TAT-CRE-recogniz ing factor upon cAMP induction, 
and dephosphorylation by specific phosphatases, which 
causes the subsequent decrease, is one possible explana- 
tion of our observations. 
In contrast to the results obtained with the TAT-  
CRE, binding activity to the somatostatin CRE is not 
affected by treatment of FTO-2B cells with forskolin or 
CHX (of. Fig. 7,C and F). In addition, it has been shown 
that phosphorylation of the CRE-binding protein (CREB) 
increases transcriptional efficacy (Yamamoto et al. 
1988), rather than influencing its binding activity in 
vitro (Montminy and Bilezikjian 1987). More recently, it 
has been demonstrated that phosphorylation of CREB at 
a specific serine residue mediated by the catalytic sub- 
unit of PK-A is responsible for this increase in transcrip- 
tional efficacy (Gonzalez and Montminy 1989). At 
present, we cannot answer the question whether the 
protein forming complex B with the TAT-CRE is re- 
lated to CREB or not. If CREB is interacting with the 
TAT-CRE,  one must postulate that both forskolin in- 
duction and CHX treatment affect the affinity of CREB 
to the TAT-CRE but do not affect binding to the so- 
matostatin CRE. We anticipate that purification of nu- 
clear factors interacting with the TAT-CRE and the so- 
matostatin CRE by DNA-affinity chromatography (Ka- 
donaga and Tjian 1986)wi l l  resolve the relationship 
between complexes A -D.  
Increased binding of a nuclear factor after cAMP stim- 
ulation to the region of the phosphoenolpyruvate car- 
boxykinase (PEPCK) gene known to contain a CRE has 
been reported by Lee et al. (1988). Its relationship to the 
TAT-CRE-binding protein is unclear; however, both 
TAT and PEPCK are predominantly expressed in the 
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same cell type. Furthermore, phosphorylation-depen- 
dent activation of binding of a transcription factor has 
been reported in the adenovirus ystem (Bagchi et al. 
1989}. 
In this study we have been able to correlate in vivo 
DNA binding with transcriptional ctivation. This is 
reminiscent of the action of the steroid hormone re- 
ceptors. Following glucocorticoid administration, pro- 
te in-DNA interactions can be demonstrated at the 
TAT-GRE, indicative of receptor binding (Becker et al. 
19861, and transcription is stimulated. However, it is 
different from the case of the c-/os-SRE, where an ap- 
parently fixed protein-DNA complex mediates ignal 
transduction (see Table 1~ Herrera et al. 1989). We 
reason that the in vivo footprint at the TAT-CRE in the 
absence of cAMP reflects basal level activity of this 
DNA-binding protein and correlates with basal level 
transcription. The observation that the unstimulated 
occupancy of the TAT-CRE is subject to turnover in 
vivo was unexpected. Because cAMP-mediated signal 
transduction through this site involves changes in 
DNA-binding activity of a protein, we conclude that the 
basal evel occupant of the site must be subject o turn- 
over to make the site responsive. This characteristic of
occupancy turnover may distinguish the mode of signal 
transduction employed by steroid hormones from that 
described here (see Table 1). Whereas the two pathways 
both deliver increased concentrations of DNA-binding 
activity to the respective response lements, they may 
differ by regulation at a post-translational level. The 
classic model of steroid hormone action involves the di- 
rect activation by ligand binding of a receptor to estab- 
lish a DNase I HS site in chromatin. Transcription is 
stimulated and persists as long as hormone is present. In 
the case described here, transcriptional stimulation cor- 
relates with a post-translational stimulation of a factor's 
cAMP-stimulated binding of a protein to a CRE 
DNA-binding activity. This takes place at a preexisting 
DNase I HS site, which is reflective of protein binding to 
the TAT-CRE in the uninduced state. Even in the con- 
tinued presence of cAMP inducers (forskolin or cAMP 
analogs), DNA-binding activity of this protein and tran- 
scriptional stimulation diminish subsequently (Hashi- 
moto et al. 1984; this work and data not shown). A com- 
parison of strategies of signal transduction is presented 
in Table 1. 
Although we show evidence indicating that the same 
DNA-binding protein mediates both basal level and 
cAMP responses, it remains unclear whether the two 
functions represent different levels of DNA-binding ac- 
tivity achieved by the same pathway or two different 
pathways that both influence the DNA-binding activity 
of this protein. Evidence places PK-A in the pathway of 
cAMP stimulation of the TAT gene, and a close correla- 
tion of basal gene transcription and PK-A activity has 
already been demonstrated for other cAMP-regulated 
genes (Day et al. 1989; Grove et al. 1989; Mellon et al. 
1989}. 
In vitro analysis of proteins by DNA-binding assays 
has been a powerful tool to characterize transcription 
factors. Nevertheless, it is often difficult to correlate in 
vitro observations with the situation in a living cell 
(Becker et al. 1987}. This is particularly relevant for the 
analysis of factors binding to CREs, given the DNA se- 
quence homologies between different CREB-, ATF-, and 
APl-binding sites and the emerging observation that 
Fos, Jun, CREB, and ATF are members of a large family 
of proteins that contain very similar DNA-binding and 
dimerization domains (Hai et al. 1988~ Hoeffler et al. 
1988~ Gonzalez et al. 1989~ Hai et al. 1989~ Hirai et al. 
1989~ Maekawa et al. 1989~ Ryder et al. 1989~ for review, 
see Mitchell and Tjian 1989}. The TAT-CRE is almost 
identical to functionally related sequences in the proto- 
Table 1. Comparison of different signal transduction pathways 
Signal transduction via induced DNA binding 
steroid hormone action 
occupancy tumover at 
the TAT- CRE 
Signal transduction via fixed 
protein-DNA complexes at 








site; no protein bound at 
responsive sites in the 
absence of hormone 
direct activation of DNA 
binding by the hormone 
activated receptor 
establishes transcription 
factor complex that 
stimulates transcription 
transcription is stimulated 
as long as hormone is 
present 
constitutive HS site; basal 
level of protein binding 
correlates with basal evel 
of gene transcription 
activation of PK-A; post- 
translational modification 
to increase DNA-binding 
activity 
increased DNA-binding 




is transient due to 
occupancy turnover at the 
responsive site 
constitutive HS site; 
constitutive protein 
binding to responsive site 
not detectable 
as yet undetermined 




transcription rate is 
down-regulated 
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oncogene c-los ( -301  to -291;  Fisch et al. 1989; Shaw 
et al. 1989)and in the human proenkephal in gene ( -94  
to -84 ;  Comb et al. 1986, 1988). Purified AP-1 binds to 
these sequences in vitro (Piette and Yaniv 1987; Comb 
et al 1988; Shaw et al. 1989), despite the absence of func- 
t ional or in vivo evidence that relates AP-1 to the cAMP 
responsiveness of these genes. Consequently,  we have 
performed in vivo analysis of DNA-prote in  interactions 
and confirmed the effects observed in vivo with in vitro 
data. Thus, we have generated criteria with which to 
identify the correct factor as a purified protein or an iso- 
lated cDNA clone. 
Mater ia ls  and methods  
Plasmid constructs 
Synthetic oligonucleotides u ed in transfection and gel retarda- 
tion experiments were synthesized on an Applied Biosystems 
synthesizer. Oligonucleotides covering the wild-type or the 
mutated TAT-CRE sequence were concatemerized and in- 
serted into the XbaI site of pBLCAT2 (Luckow and Schiitz 
1987). Recombinant plasmids containing six direct repeats of 
either oligonucleotide in the sense orientation were used in the 
transient transfection experiments. Constructs used for stable 
transfections are based on the plasmid TATCAT-4289/+ 62, 
which is described in Boshart et al. (1990). The end points of 
TATCAT-3675 and TATCAT-3628 correspond to SphI and 
A vaII restriction sites in the TAT sequence, respectively. 
TATCAT-3675/M3 was generated by the oligonucleotide cas- 
sette technique (Grundstr6m et al. 1985). A 131-bp SphI 
(-3675)-XbaI (-3544)fragment was replaced by 14 assembled 
oligonucleotides that contained a triple-point mutation at the 
TAT-CRE. All constructions were verified by restriction en- 
zyme digestions and plasmid sequencing (Chen and Seeburg 
1985). The neo gene driven by the TK promoter was used as a 
selectable marker (pTKneo; M. Boshart, unpubl.). 
Cell culture 
FTO-2B cells were grown to confluency in DMEM/Ham's F12 
(1 : 1)with 10% fetal calf serum, 2 mM glutamine, 100 U/ml 
penicillin, 100 ~g/ml streptomycin, and 10 mM HEPES (pH 7.4). 
XC cells were cultured in DMEM instead of DMEM/Ham's 
F12. Prior to harvesting, cells were incubated for 12-18 hr in 
serum-free medium, followed by a change to medium that con- 
tained 10 ~M forskolin (Calbiochem) or 0.1% ethanol as solvent 
control. Induction times ranged from 30 to 250 rain. For CHX 
experiments, cells were treated for 45-250 min with 50 ~g/ml 
CHX (Sigma) after overnight incubation in serum-free medium. 
DNA transfections and generation of stably transfected 
cell lines 
FTO-2B cells were transfected by electroporation (Fromm et al. 
1985; Chu et al. 1987). Transfections and CAT assays were per- 
formed as described in detail by Boshart et al. (1990). For stable 
transfections, TATCAT constructs were cotransfected with the 
selectable neo gene into FTO-2B cells by electroporation. 
Vector sequences of both plasmids were removed by gel purifi- 
cation prior to transfection. After 3 days, culture medium was 
changed to DMEM/Ham's F12, including 800 ~g/ml G 418 
(GIBCO). After 10 additional days, G 418-resistant cells (I> 850 
individual colonies per transfection)were pooled, split onto 
separate dishes, and used for RNA preparation after forskolin 
induction. 
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FTO-2B and XC cells were treated with serum-free media for 12 
hr and induced with dexamethasone (1 ~M)or cAMP (0.5 mM 
8-4-chlorophenylthio-cAMP; Boehringer-Mannheim)for 1 hr. 
All other methods were as described previously (Jantzen et al. 
1987), except hat a 1% agarose gel was employed and soak- 
blotted to Pall Biodyne B according to the manufacturer's ec- 
ommendations. The probe EB670 was cloned into Bluescribe 
M13- (Stratagene)and used as the template for T3-RNA poly- 
merase transcription by standard procedures (Melton et al. 
1984). 
Genomic footprinting, probe synthesis, and hybridization 
Routinely, one to two dishes (15 cm, 0.5 x 10 s to 1 x 10 s cells) 
were collected by mild trypsinization and resuspended in 1 ml 
of serum-free medium or in medium containing either 10 ~M 
forskolin, 50 ~g/ml CHX, or both. The subsequent s eps were 
carried out as described in detail by Becket and Schlitz (1988). 
The probe HS127 (Fig. 2) was cloned into SacI- and SphI-di- 
gested Bluescribe M13-. The vector and the probe fragment 
were treated with T4-DNA polymerase to generate blunt ends 
according to Maniatis et al. (1982). Identity and orientation 
were verified by supercoil sequencing (Chen and Seeburg 1985). 
Synthesis of single-stranded cDNA probes of high specific ac- 
tivity from RNA templates by reverse transcription was as de- 
scribed (Weih et al. 1988). 
Hybridizations were performed according to Church and Gil- 
bert (1984), with modifications (Becker and Schiitz 1988), ex- 
cept that presaturation of vector-specific sequences with 
sheared single-stranded vector DNA was omitted. 
RNA analyses 
RNA was prepared according to Cathala et al. (1983). Correctly 
initiated transcripts of stably transfected TATCAT constructs 
were quantitated by a ribonuclease protection experiment 
(Melton et al. 1984). Total RNA (40 ~g)was hybridized with 10 
fmoles (6 x l0 s cpm) of a uniformly labeled and gel-purified 
SP6 transcript, covering positions - 108 to + 216 of pTATCAT 
IJantzen et al. 1987), and digested for 1 hr at 30°C with 10 ~g/ml 
RNase A and 100 U/ml RNase T1. Northern gels were run with 
10 ~g of total RNA per lane as described by Schmid et al. (1987). 
Nuclear un-on analysis 
FTO-2B cells for run-on analysis were either induced with 10 
~M forskolin or uninduced. The run-on transcription reactions 
were performed as described previously (Stewart and Schiitz 
1987). The following plasmids were immobilized on the filters: 
for TAT, 0.5 pmole each of pTATEHO.95, pTATEH2.45, and 
pTATEE1.05 (Hashimoto et al. 1984); for GAPDH, 0.5 pmole of 
pGAPDH (Fort et al. 1985); for Bluescribe, 1.5 pmole was em- 
ployed. 
Preparation of nuclear extracts 
Nuclear extracts were prepared as described by Dignam et al. 
(1983), with modifications (Wildeman et al. 1984). The extracts 
were finally dialyzed against 20 mM HEPES/KOH (pH 7.9), 20% 
glycerol, 20 mM KC1, 2 mM MgC12, 0.2 mM EDTA, 0.5 mM 
DTT, and 0.5 mM PMSF. Nuclear extracts from uninduced and 
forskolin-induced FTO-2B cells were prepared in the presence 
of phosphatase inhibitors. Briefly, after incubation on ice for 10 
min in hypotonic buffer, cells were collected by centrifugation 
and resuspended in hypotonic buffer containing in addition 20 
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mM Na2HPO 4 (pH 7.2), 5 mM NaF, and 0.2 mM (NH4)6MoTO24. 
These inhibitors were also added to all buffers used in the suc- 
ceeding preparation steps. 
Gel retardation assays 
The oligonucleotides u ed in the gel retardation assays (Fig. 3B) 
were cloned into Bluescribe vectors. The sequence of the so- 
matostatin CRE oligonucleotide is given for the upper strand 
from position - 56 to - 31: 5'-TCCTTGGCTGACGTCAGA- 
GAGAGAGT-3'. After linearization with either HindIII or 
EcoRI within the polylinker, the resulting 5'-protruding ends 
were filled with Klenow enzyme and labeled with [~-a2P]dATP. 
The labeled DNA was restricted with EcoRI or HindIII, respec- 
tively; the fragment of interest was purified over a 10% poly- 
acrylamide gel and eluted from the gel overnight at 37°C (Man- 
iatis et al. 1982). Twenty-five micrograms of nuclear protein 
was routinely incubated with 1 ~g of sonicated herring sperm 
DNA in binding buffer consisting of 10 mM HEPES/KOH (pH 
7.9), 15% glycerol, 30 mM KC1, 5 mM MgC12, 4 mM spermidine, 
0.1 mM EDTA, 0.25 mM DTT, and 0.25 mM PMSF in a total 
volume of 9 ~1 for 15 rain on ice. To this, 1 ~1 (5 fmoles) of 
specific end-labeled fragment {20,000 cpm/~l)was added, and 
incubation was continued for 15 rain on ice. For competition 
experiments, 0.25-2 pmoles (50- to 400-fold molar excess) of 
unlabeled DNA fragments was added to the reaction mixture 
shortly before the labeled fragment. Samples were loaded onto 
4% native polyacrylamide g ls and separated by electrophoresis 
in 30 mM Tris-borate buffer {pH 8.4) at 9 V/cm. Gels were dried 
and autoradiographed (Fried and Crothers 1981; Garner and 
Revzin 1981). 
Methylation interference studies 
End-labeled DNA fragments were partially rnethylated with 
DMS by standard procedures (Maxam and Gilbert 1980). The 
amount of DNA used for 10 analytical gel retardation reactions 
was loaded onto a preparative 4% polyacrylamide g l and, after 
separation, visualized by autoradiography. Material corre- 
sponding to bound and free fractions was cut out, and DNA was 
recovered by isotachophoresis (Ofverstedt et al. 1984). After 
phenol/chloroform (1:1)extraction and addition of carrier, 
DNA was precipitated with ethanol. Samples were subse- 
quently cleaved with piperidine, ethanol-precipitated, and dried 
for several hours in the SpeedVac oncentrator. Equal amounts 
of radioactive material resuspended in formamide loading 
buffer were applied to a 10% sequencing el (Siebenlist and 
Gilbert 1980). 
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